Latest filing published 18 Sept 2026 for Sionna Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jennifer Fitzpatrick: trading record in brief
This profile gathers the share dealings of Jennifer Fitzpatrick in Sionna Therapeutics, Inc. In total, 10 filings cover trades dated from 4 September 2025 to 17 September 2026.
The open-market record consists of 4 sales worth €1.2M, with no purchase. Other entries cover 2 share grants and 4 option exercises. Since January 2026: no purchases and 2 sales on the market.
The newest entry dates from 18 September 2026: a share grant, in Sionna Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jennifer Fitzpatrick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 28,133 shares0Common StockSEC:0002061851-26-000009:0
- 28,132 shares0Common StockSEC:0002061851-26-000009:1
- 10,250 shares@ US$6.110.024% mcap12.3% of flowCommon StockSEC:0002061851-26-000006:0
- 10,250 shares@ US$43.59630.17% mcap87.7% of flowCommon StockSEC:0002061851-26-000006:1
- 10,250 shares@ US$6.118.9% of flowCommon StockSEC:0002061851-26-000004:0
- 10,250 shares@ US$6.119.7% of flowCommon StockSEC:0002061851-25-000003:0
- 10,250 shares@ US$6.1110.8% of flowCommon StockSEC:0002036042-25-000055:0
7 of 7 declarations
